The purpose of this review is to summarize the literature on thoracic aortic surgery, as well as key management guidelines in the perioperative period. This is particularly timely, as endovascular techniques continue to evolve and become more available.
INTRODUCTION
Descending thoracic aorta (DTA) disease continues to plague patients in 2012. As the number of elderly and comorbid patients with thoracic aortic disease is expected to increase sharply in the next 10-15 years, and blunt and penetrating aortic trauma continues to claim victims annually, the optimal surgical approach and perioperative risk reduction strategies for thoracic aortic pathology are in flux. Endovascular techniques offer the potential to treat higher-risk patients with a minimally invasive approach, but add (most commonly) extra risk of stroke, spinal cord ischemia (SCI) and renal dysfunction. This review analyzes the recent literature on preventing morbidity after DTA surgery, with specific attention to risk reduction and management in the perioperative setting.
RESEARCH METHODOLOGY
Authors searched PubMed, Cochrane databases and the Internet using search engines Google, Yahoo and Bing for primary research studies published from 1 July 2010 through 1 March 2012, using terms, including descending, thoracic, aorta, aortic, surgery, aneurysm, dissection, stroke, SCI, renal failure, morbidity, risk, assessment, management, intensive care and postoperative. Two hundred ninety-eight discrete studies were identified, of which 51 are discussed below. National society guideline statements will be discussed in limited detail if published before July 2010. General exclusion criteria included reviews, studies that included significant patients with ascending aorta or aortic arch pathology and studies that focused on diagnostic imaging. There has been a noticeably large number of publications on endovascular approaches to the thoracic aorta in the review period. mortality data must be closely scrutinized as increasingly sicker and older patients are offered the less invasive endovascular approach and as this technique disseminates into institutions that are not designated 'centers-of-excellence.' Moreover, the Walker study showed that diagnostic computed tomography scans and total and endovascular DTAA repairs have increased from 2000 to 2007, and that these trends are expected to continue. In addition, the endovascular approach appears to be associated with short-term lower complication rates overall, shorter length of stay (LOS), greater likelihood of discharge to home, but higher hospital costs [1] .
OPEN VERSUS ENDOVASCULAR REPAIR
Although previous studies reported singleinstitution short-term outcomes, the report of Goodney et al. [3 && ] supports the perioperative mortality benefit of endovascular repair of unruptured DTAA (6.1 versus 7.1%) and ruptured DTAA (28 versus 46%) over an open approach in a nationwide Medicare population. They reported midterm to long-term outcomes, but worse survival rates at 1 year (82 versus 87%) and 5 years (62 versus 72%) for patients who underwent endovascular DTAA repair compared to open surgery, respectively. Another study [4] showed similar long-term survival rates for the endovascular approach at 86, 60 and 42% at 1, 5 and 10 years, respectively. The Goodney et al. [3 && ] study also suggested that the older, sicker patients are being offered the endovascular approach, but that this survival difference persists even after adjusting for risk factors. A known limitation of using national administrative databases for research studies is that they often contain insufficient anatomic and procedural detail to interpret the results. A national registry that captures this information is under development, and will be instrumental for future population studies on midterm and long-term outcomes.
The 1-year mortality rate for thoracic endovascular aneurysm repairs (TEVARs) has been highly variable in previous studies, ranging from 4 to 39%. For patients who underwent TEVAR at a single institution and had a mean follow-up period of 22 months, Chung et al. [5] recently reported that multivariate predictors of late mortality included aortic rupture, debranching, preoperative leukocytosis and (larger) aneurysm diameter. Studies prior to July 2010 have also reported an association between elevated white blood cell count and mortality in TEVAR patients, but further prospective trials with national populations need to be conducted to confirm this as a risk factor.
RUPTURED DESCENDING THORACIC AORTIC ANEURYSM REPAIR
As endovascular techniques continue to proliferate, treating ruptured DTAAs represents an expanding role for TEVAR. In a recent nationwide study of ruptured aneurysm patients, Gopaldas et al. [6] report an unadjusted mortality benefit to the TEVAR approach compared with open surgery (23.4 versus 28.6%), but this mortality benefit does not remain statistically significant after adjustment. Another multicenter study [7] suggests a trend toward survival benefit for TEVAR patients at 4 years of followup (75.2 versus 64.3%), but it was not statistically significant (P ¼ 0.191). Jonker et al. [7] , however, did report that TEVAR (21.7%) was associated with a KEY POINTS Endovascular approaches to thoracic aortic surgery, including repair of descending and thoracoabdominal aortic aneurysms, type B dissections and traumatic aortic injury, are increasing in frequency.
TEVAR offers a reduction in pulmonary complications, blood product transfusions and hospital length of stay compared with open repairs for most applications.
The combined risk of stroke and spinal cord injury from TEVAR is not significantly different from open repairs.
There may be long-term mortality benefits from elective open surgical approaches for descending aortic aneurysmal disease compared to endovascular approaches.
TYPE B AORTIC DISSECTION
In addition to ruptured DTAAs, the endovascular approach has been applied to acute type B aortic dissections (TBADs), with meta-analyses reporting TEVAR mortality rates from 1.2 to 14%. Another study that used the NIS population data [8] reported an in-hospital mortality benefit of endovascular repair over open surgery (10.6% versus 19.0%), despite offering TEVAR to older, sicker patients. Botsios et al. [9] report an in-hospital mortality rate for endovascular patients of 9.3%. Moreover, the Sachs group [8] showed a higher rate of complications and longer LOS with open surgery for TBAD repair. Other studies report a 30-day mortality for endovascular TBAD repair ranging from 10.8 [10] to 22% [11] , and a 1-year mortality of 29.4% [10] . During treatment of acute TBAD, the most commonly reported complications involved hemorrhage and cardiac, respiratory, neurologic and renal systems.
Patients who present with chronic TBAD represent another population to which endovascular technology has been applied. Survival with medical therapy is currently equivalent to (and possibly better than) TEVAR (97.0 versus 91.3%) for chronic dissection after 1 year of follow-up [12] . Endovascular survival rates have also been reported at 86, 82 and 80% at 12, 24 and 36 months [13] , and up to 77.7% at 60 months [14] for this population. Furthermore, as operator experience grows, the use of multistent repairs and exclusion of other complex aortic pathology have been reported [15, 16] . For open thoracic aortic procedures, however, chronic dissection does not add an increased risk of SCI or mortality compared with degenerative aneurysms [17] .
DEBATE OVER OPTIMAL APPROACH FOR DISTAL DESCENDING THORACIC AORTIC ANEURYSM REPAIR
Although longer term outcome studies continue to be published, debate continues regarding the optimal approach to treat distal (type IV) thoracic aneurysms. Single-center rates of mortality and paraplegia have declined in the past 25 years [18] , but may still exceed 20% using larger population studies. In recent studies for open repair of type IV aortic aneurysm, the risk of 30-day mortality was as low as 2.8%, risk of myocardial infarction (MI) 3.4%, risk of dialysis 2.8% and SCI 2.2% [19] or paraplegia 3.0% [20] . Moreover, some centers have experimented with distal aortic perfusion [20] and repair of more complex, infected aneurysms [21] . Not unexpectedly, a history of cerebrovascular disease and postoperative renal insufficiency have been reported as independent mortality risk factors for up to 5 years after open repair [22] . Although the intended focus of this review is primary research on thoracic aortic surgery and perioperative risk management, a recent group of articles summarizes single-institution studies and highlights a rather unique trans-Atlantic debate on the optimal surgical approach to repair type IV aortic aneurysms in the stent graft era [23] . [24] suggest that endovascular repair of isolated abdominal aortic aneurysms (AAA) is associated with a short-term mortality benefit compared to open repair (2.3 versus 8.6%) in patients older than 80 years, but this benefit is lost after 3 years follow-up [24] . In this population, open repair was a significant risk factor for cardiac, pulmonary and renal complications.
TRAUMA
Historically, treatment of thoracic aortic trauma has been via open repair, which often required multiple transfusions and cardiopulmonary bypass. As endovascular techniques proliferate, new approaches to treat traumatic aortic injury are being developed. Rahimi et al. [25] reported a series of 18 thoracic aortic transections due to trauma that were treated with an endovascular technique. Although 50% of patients required coverage of the left subclavian artery, they reported no postoperative paraplegia. A 2012 national trauma study showed that the total number of endovascular procedures performed to treat arterial injury has increased substantially since 2008 [26 & ]. When performed early on arrival, the endovascular repair showed a lower risk of mortality [26 & ], as has one other recent study [27] . Similarly, Hong et al. [28] reviewed the NIS and also showed an increase in TEVAR performed for traumatic aortic injuries. This study, however, reported that the mortality rates between TEVAR and the open repair groups (10.6 versus 12.4%, respectively) were not significantly different. Of note, endovascular patients had significantly higher rates of concomitant brain injury, lung injury and hemothorax than the open repair group on presentation. Postoperatively, TEVAR patients were at greater risk of stroke, and open repair patients had more respiratory complications. Nevertheless, exactly how endovascular treatment will change the management of traumatic aortic injuries remains to be determined, yet studies have been published that evaluated selective nonoperative strategies [29] [30] [31] and whether endovascular strategies are cost-effective in this setting [32] .
NEUROLOGIC RISK
Neurologic injury is a known potential complication of thoracic aortic surgery via either endovascular or open repair. Recent single-center studies report the incidence of SCI during endovascular repair ranging from 2.8 to 9.8% [33 & ,34-36] . Providers have implemented protocols to protect or rescue the spinal cord from ischemic threat during DTAA surgery, including distal aortic perfusion, surgical hypothermia and pre-emptively placed lumbar spinal drains [33 & ,35] . Recently reported risk factors for SCI include preoperative renal insufficiency [33 & ], proximal landing zone location [34] , length of aortic coverage [34, 36] , distal aortic noncoverage [34] as well as operative time and number of stents placed [36] . Additional historic risk factors for SCI during open surgery include emergent presentation, aortic cross-clamp time and previous AAA repair. SCI often presents as paraparesis, paraplegia or frank leg pain. If lumbar drainage catheters are present (or soon placed) at the onset of SCI, catheters are unclamped, checked for patency and drained to achieve cerebrospinal fluid pressures of 10 mmHg or lower [33 & ,34-38] . Some providers, however, stop drainage at an hourly maximum of 10 or 20 ml of drainage for fear of tearing intracranial vessels or causing brain herniation [38] . See Table 1 for risks of lumbar spinal drains [38] . Concurrent pharmacologic elevation of mean arterial blood pressure (MAP) is advocated to a MAP greater than 90 or 100 mmHg, or SBP of 160 mmHg [33 & ,35,38] . In addition, some centers have used hypothermic circulatory arrest specifically to try to minimize injury to the nervous system [39] . Other centers have investigated the use of motor-evoked potentials to monitor for signs of SCI, but with unreliable predictability [40] . Although stroke is a known complication of thoracic aortic repair, there have been few studies published since July 2010 specifically addressing this topic. Recent studies reported postoperative stroke rates of TEVAR ranging from 3.0 [35] to 7.6% [41] . Three studies have reported stroke rates during open thoracic or DTAA repair from 3.7 to 11% [39, 42, 43] . Other than age [40] and heavy aortic atherosclerotic load, and possibly length of surgical time or hypotension, relatively little is known to predict the risk of stroke. Kulik et al. [39] report that neither the cause of the aortic disease or the extent of aortic repair was significantly associated with the risk of stroke.
CARDIAC RISK
Coronary artery disease (CAD) is highly prevalent (30-70%) in patients with aortic aneurysm. Although many national cardiac societies have published guidelines on management of CAD for patients who need noncardiac surgery, very few studies in the recent literature have been able to conclusively define the risk factors for cardiac events and thoracic aortic surgery. Bub et al. [44 & ] evaluated the association between cardiac studies and perioperative cardiac outcomes in patients with thoracoabdominal or juxtarenal aneurysms. Univariate analysis showed that mitral annular calcification was associated with MI, and that left atrial size, left ventricular ejection fraction and left ventricular mass were associated with ventricular arrhythmias within 30 days. Only left atrial size remained associated with arrhythmia after multivariable analysis. In patients without cardiac symptoms, the routine use of preoperative stress testing failed to be associated with significant benefit [44 & ].
SEX, AGE
In studies prior to July 2010, sex has not been recognized as a major risk factor for repair of DTAAs. Although vessel size has been studied in AAA patients, in women with significantly smaller iliac vessels, two recent studies have reported higher rates of vascular complications and higher rates of requirement for iliac conduit during TEVAR compared to men [45, 46] , suggesting a lower threshold for elective conduit use in women [45] . Jackson et al. [46] reported that the incidence of 30-day adverse events was greater with women than men (52.5 versus 33%), and technical TEVAR treatment slightly favored women (98.2 versus 82.4%). Larger prospective randomized trials are likely still necessary to evaluate a true difference in technical TEVAR success between men and women. In addition to sex, historically, age has been suggested as a possible risk factor during DTAA repair, perhaps due to a greater degree of comorbid disease or other Adapted from [38] .
unknown causes. Recently, in a study of 226 consecutive TEVAR patients, Czerny et al. [47] reported that patients older than 75 years had increased rates of extracardiac arteriopathy and were more likely to be deemed inoperable via open surgery. Older patients were more likely to suffer MI, neurologic insult and endoleaks than their younger counterparts, but emergency status was the only mortality risk factor that remained after adjustment [47] . In a study of patients older than 80 years comparing endovascular versus open AAA repair [24] , the open surgical approach was associated with higher postoperative cardiac, pulmonary and renal complications.
RENAL
Although renal failure rates vary between 2 and 10% in DTAA repairs, some centers claim beneficial results due to renal protection protocols [18] . University of Wisconsin researchers implemented a renal cooling protocol to protect the kidneys from permanent damage and minimize transient failure. Chronic renal insufficiency was identified as an independent predictor of perioperative complications, including death [19] . Pisimisis et al. [48] reported risk factors for acute and late renal dysfunction (shown in Table 2 ) [48] , including intraoperative hypotension and age, respectively. Interestingly, in that study obesity appeared to be nephroprotective. A recent study has also reported chronic dissection, hybrid procedure and presence of connective tissue disease as predictors of need for reintervention [51] . TEVAR patients will continue to need surveillance imaging studies at 30 days, 6 months, and then annually for an indefinite period of time.
ICU/POSTOPERATIVE RECOVERY

CONCLUSION
In summary, surgical approaches to thoracic aortic disease have undergone dramatic changes with the advent of and growing experience with endovascular techniques developed in the past decade. Although early experience was largely centered on TEVAR techniques and feasibility, the recent literature has focused on long-term outcomes in comparison to open repairs of thoraco-AAAs, TBADs and traumatic aortic injuries. Debate continues as to the optimal approach for surgical repair of these complicated lesions. Although TEVAR may offer reductions in pulmonary complications, blood transfusions and LOS compared to open procedures, the benefits of minimally invasive approaches with respect to total costs, neurologic outcomes, renal dysfunction and long-term mortality remain largely unproven.
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